comprehensive -WSS

comprehensive

author：comprehensive 2025-10-01 00:30:39 - browse：22241

House Judiciary Chairman Jerrold Nadler (D-NY) listens as Rep. Judy Chu (D-CA) speaks during a news conference. — Reps. Jerry Nadler (D-N.Y.) and Judy Chu (D-Calif.) Joshua Roberts/Getty Images

House Democrats are raising concerns with the Biden administration that Medicare Advantage plans need better oversight, citing recent STAT investigations that found insurance companies are using artificial intelligence and algorithmic software to deny care even when people still need it.

On Friday, Rep. Judy Chu of California and Rep. Jerry Nadler of New York spearheaded a letter to the Centers for Medicare and Medicaid Services asking the agency to step up its oversight of Medicare Advantage insurers. Thirty other House Democrats also signed onto the letter.

STAT previously reported Medicare Advantage insurers are using proprietary algorithms and AI to initiate payment denials, but that technology does not fully account for someone’s particular care needs. As a result, many frail patients have been kicked out of nursing homes, faced the prospect of draining their savings, or slogged through a long appeals process to get care they and their clinical teams think they need.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： The tragedy of Johnson & Johnson’s Covid vaccine

focus

WSS

Testing for cancer recurrence creates a new limbo for patients

Diversifying clinical trials isn't enough to close racial gaps: study

EU regulator recommends expanding Mounjaro approval to obesity

Maker of FluMist seeks to allow at

Humana cuts profit projections as Medicare Advantage costs soar

Elizabeth Holmes banned from government health programs

hotspot

comprehensive

explore

Continuity nursing helped my family in our darkest PICU moments

Traditional Chinese medicine benefits explored in new JAMA study

United colonoscopy coverage change 'may cost lives,' doctors say

Francis Collins on trust in science and how Covid communications failed

In age of alternative facts, a scholarly course on calling out crap

FDA approves Eli Lilly ulcerative colitis treatment Omvoh

23andMe had bad news about my health. I wish a person had delivered it

Parkinson’s finding may lead to tests and, someday, treatments

Walensky prepares to leave CDC — and Congress — behind

Dewpoint Therapeutics lays off staff after losing partnerships

hotspot

Readout Newsletter: New research from Sanofi, Regeneron, etc.

Meta's Zuckerberg and Chan on track to put $50 billion into science

AI generated plenty of interest at JPM but not a lot of trust

Readout Newsletter: What happened with Sarepta's Duchenne data

Research misconduct: Proposed new rules face resistance

Biden's order seeks to regulate AI risk without stifling innovation

hotspot

entertainment

focus

focus